Clinical Trials Logo

Chest Tubes clinical trials

View clinical trials related to Chest Tubes.

Filter by:
  • None
  • Page 1

NCT ID: NCT06217263 Not yet recruiting - Pain, Postoperative Clinical Trials

Effect of Vibration and Cold Application on Chest Tube Removal Pain After CABG

CABG
Start date: January 30, 2024
Phase: N/A
Study type: Interventional

After cardiothoracic surgery, a chest tube is placed in patients to maintain hemodynamic stability and cardiopulmonary function by evacuating air, blood, and fluid accumulated in the pleural, pericardial, or mediastinal space, and to prevent undesirable conditions such as pneumothorax, hemothorax, and pleural effusion. Chest tube removal (CTR); it is an experience that can cause moderate or severe pain and anxiety in patients due to friction and separation from the endothelium and other surrounding tissues in the entry area of the tube. Analgesic methods are often preferred in pain management. However, research reveals that patients experience pain during CTR despite the use of analgesics and anesthetics. Although pharmacological agents are the most commonly used method for pain relief during CTR, studies report that the response to pharmacological treatment is variable and may be inadequate for pain management during and after CTR, making pain management difficult. Considering that procedure-related anxiety disrupts the physiological and emotional state of the patient and the side effects and possible complications of analgesics used in pain management, such as respiratory distress and nausea, the importance of nurses' use of non-drug methods in reducing pain during CTR increases This research was designed as a randomized controlled experimental study to determine the effect of vibration and cold application on pain and anxiety associated with chest tube removal after coronary artery bypass graft surgery. The research was planned to be conducted in the Cardiovascular Surgery Intensive Care Unit and Surgical Services of a Thoracic and Cardiovascular Surgery Training and Research Hospital in Istanbul between January 2024 and January 2025. Patients' pain will be evaluated using VAS, blood pressure, and respiratory rate using a patient monitor, pulse and oxygen saturation using a pulse oximeter device, and the temperature of cold application gels using a digital infrared thermometer. All data will be collected by the same researcher, with the same tools and methods. A "data form" developed in line with the literature and STAI I-II (State and Trait Anxiety Scale) will be used as data collection tools.

NCT ID: NCT06036667 Completed - Pleural Effusion Clinical Trials

Safety and Efficacy of Coaxial Smart Drain (Redax TM) in Uniportal-VATS

Start date: March 5, 2019
Phase: N/A
Study type: Interventional

The aim of the study is to evaluate efficacy and safety of "Smart Coaxial drain" (Redax TM, Poggio Rusco, Mantova, Italia) in terms of total amount of effusion drained, incidence of residual effusion at Chest X-Ray and patient's comfort in Uniportal- and Biportal-VATS upper lobectomies. In particular, to evaluate in Uniportal-VATS upper lobectomies the efficacy and safety of smart coaxial drains compared with standard silicone chest tubes.

NCT ID: NCT05384327 Completed - Chest Tubes Clinical Trials

Development and Validation of a Theoretical Test for Chest Tube Insertion

Start date: May 5, 2022
Phase: N/A
Study type: Interventional

The goal of the proposed study design is to develop and gather validity evidence of a theoretical test about cognitive skills which are important when performing Chest Tube Insertion (CTI). This study consists of two parts: - The development of the theoretical test and its items. The test content will be based on a broad literature search, and on semi-structured interviews with content experts. - The subsequent collection of validity evidence for this theoretical test and final selection of the test items, by testing groups that differ based on their expertise. The item analysis and observed difference in mean score between the groups will provide the validity evidence.

NCT ID: NCT04718272 Recruiting - Clinical trials for Minimally Invasive Surgery

Safety and Feasibility of the Application of Thoracic Puncture Tube After Pulmonary Lobectomy

Start date: January 25, 2021
Phase: N/A
Study type: Interventional

There have been several reports on the feasibility of a no-drain policy after pneumonectomy, but the policy is not widely accepted because silent massive hemorrhage, delayed air leaks, and chylothorax would always be major worries for thoracic surgeons, and all of the researches were retrospective case studies with small sample size and insufficient evidence. Therefore, the purpose of this study is to to evaluate safety and feasibility of an improved policy, the application of a small thoracic puncture tube after pulmonary lobectomy.

NCT ID: NCT04669223 Recruiting - Clinical trials for Pleural Effusion, Malignant

Comparing Different Sizes of Small-bore Chest Drains in Malignant Pleural Effusion

Start date: December 1, 2020
Phase: N/A
Study type: Interventional

Malignant pleural effusion (MPE) is a very common medical condition, especially among patients with disseminated cancers. Chest drain insertion aims to drain the pleural fluid collection and relieve dyspnea. Small bore chest tubes are recommended as the first line therapy for draining pleural effusions. However, there is no clinical data available to inform on the size of drains for better drainage. This is a randomized study comparing the two common bores of small bore chest drains in Hong Kong, and assess for its clinical efficacy and complication risks.

NCT ID: NCT00925444 Completed - Lung Neoplasms Clinical Trials

Staple-line Reinforcement for Prevention of Pulmonary Air Leakage

SPIRAL
Start date: June 2009
Phase: Phase 4
Study type: Interventional

The aim of this study is to compare the efficacy of FORESEAL with stapling alone or associated with tissue sealant or glue in terms of air leakage duration after lung resection for cancer. Hypothesis: to show a significant difference of 1 day in the average duration of air leakage between the 2 groups with a standard deviation of 3 (α =0.05 and β=0.10).